GlassScriptPhysician profile
Xun Li
NPI 1003158163
$23,601.52
in general payments reported to CMS, 2019-2025
14 companies · $1,707 in 2025
The $1,707 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $60.00 · 2021: $1,352 · 2022: $12K · 2023: $3,939 · 2024: $2,911 · 2025: $1,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,310 · Food and Beverage: $2,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,310.21 |
| Food and Beverage | $2,246.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seaspine Orthopedics Corporation | $5,794.16 | 2022 | |
| Stryker Corporation | $5,213.14 | 2019-2024 | Cascadia Interbody System |
| Medtronic, INC. | $4,045.77 | 2022-2025 | Stealthstation S8 Platform, Unid_pass, Mazor X System |
| Nuvasive, INC. | $2,873.10 | 2022 | |
| Si-Bone, INC. | $1,745.33 | 2021-2023 | |
| Globus Medical, INC. | $1,457.88 | 2021-2023 | Creo Mis Stabilization System, Mars Anterior Retractor |
| Suvon Surgical LLC | $836.48 | 2025 | |
| Arthrex, INC. | $616.40 | 2025 | |
| Zimvie INC. | $554.46 | 2022-2023 | |
| Boston Scientific Corporation | $152.85 | 2023 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $124.45 | 2022 | |
| Biocomposites INC | $107.20 | 2024 | |
| Medtronic USA, INC. | $60.00 | 2020 | |
| Intrinsic Therapeutics | $20.30 | 2025 | Barricaid Acd (Annular Closure Device) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xun Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.